Your browser doesn't support javascript.
loading
Pharmacological targets and emerging treatments for respiratory syncytial virus bronchiolitis.
Elawar, Farah; Oraby, Ahmed K; Kieser, Quinten; Jensen, Lionel D; Culp, Tyce; West, Frederick G; Marchant, David J.
Afiliação
  • Elawar F; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
  • Oraby AK; Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Misr University for Science &Technology, Al-Motamayez District, 6th of October City, P.O. Box 77, Egypt.
  • Kieser Q; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
  • Jensen LD; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
  • Culp T; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2R3, Canada.
  • West FG; Department of Chemistry, University of Alberta, Edmonton, Alberta T6G 2G2, Canada.
  • Marchant DJ; Li Ka Shing Institute of Virology, Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, AB T6G 2R3, Canada. Electronic address: marchant@ualberta.ca.
Pharmacol Ther ; 220: 107712, 2021 04.
Article em En | MEDLINE | ID: mdl-33121940
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Vírus Respiratório Sincicial Limite: Humans Idioma: En Revista: Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Infecções por Vírus Respiratório Sincicial Limite: Humans Idioma: En Revista: Pharmacol Ther Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Canadá